Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca(v)1.2 calcium channels.

British Journal of Pharmacology
Heng Yu ZhangTuck Wah Soong

Abstract

As a calcium channel blocker, diltiazem acts mainly on the voltage-gated calcium channels, Ca(v)1.2, for its beneficial effects in cardiovascular diseases such as hypertension, angina and/or supraventricular arrhythmias. However, the effects of diltiazem on different isoforms of Ca(v)1.2 channels expressed in heart and vascular smooth muscles remain to be investigated. Here, we characterized the effects of diltiazem on the splice variants of Ca(v)1.2 channels, predominant in cardiac and vascular smooth muscles. Cardiac and smooth muscle isoforms of Ca(v)1.2 channels were expressed in human embryonic kidney cells and their electrophysiological properties were characterized using whole-cell patch-clamp techniques. Under closed-channel and use-dependent block (0.03 Hz), cardiac splice variant Ca(v)1.2CM was less sensitive to diltiazem than two major smooth muscle splice variants, Ca(v)1.2SM and Ca(v)1.2b. Ca(v)1.2CM has a more positive half-inactivation potential than the smooth muscle channels, and diltiazem shifted it less to negative potential. Additionally, the current decay was slower in Ca(v)1.2CM channels. When we modified alternatively spliced exons of cardiac Ca(v)1.2CM channels into smooth muscle exons, we found that all...Continue Reading

References

Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R J DieboldA Schwartz
Aug 1, 1991·The Journal of General Physiology·R W Hadley, W J Lederer
Jul 1, 1994·Genomics·N M Soldatov
Oct 4, 1996·The Journal of Biological Chemistry·S HeringH Glossmann
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·S HerlitzeW A Catterall
May 19, 1998·Trends in Pharmacological Sciences·J StriessnigH Glossmann
Oct 9, 1998·The Journal of Biological Chemistry·R L KrausJ Striessnig
Nov 5, 1999·The New England Journal of Medicine·D R Abernethy, J B Schwartz
Nov 27, 1999·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·J Striessnig
Nov 28, 2000·Molecular Pharmacology·G H HockermanW A Catterall
Jun 27, 2003·Cellular and Molecular Neurobiology·David J Triggle
Sep 24, 2004·The Journal of Biological Chemistry·Ping LiaoTuck Wah Soong
Jul 30, 2005·Cardiovascular Research·Ping LiaoTuck Wah Soong
Jun 7, 2006·The Journal of Biological Chemistry·Igor SplawskiMark T Keating
Oct 20, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yiru ShenTuck Wah Soong
Feb 20, 2007·Current Medicinal Chemistry·Roberta BudriesiRraffaella Spisani
Jan 20, 2009·Pflügers Archiv : European journal of physiology·Ping LiaoTuck Wah Soong
Mar 6, 2009·Pflügers Archiv : European journal of physiology·Ping LiaoTuck Wah Soong
Nov 4, 2009·British Journal of Pharmacology

❮ Previous
Next ❯

Citations

Jun 6, 2015·Journal of Ginseng Research·Cheng LuLine Wang
Nov 28, 2013·Pharmaceuticals·Gene GurkoffRobert Berman
Oct 27, 2010·British Journal of Pharmacology·W ShabbirS Hering

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Related Papers

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Jin TaoShengnan Li
Annual Review of Cell and Developmental Biology
W A Catterall
Annual Review of Neuroscience
S Hagiwara, L Byerly
© 2021 Meta ULC. All rights reserved